Proceedings: Antihypertensive activity of a new 3-hydrazinopyridazine derivative: ISF 2123.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004285:Dogs; D006439:Hemodynamics / Q000187:drug effects*; D006834:Hydrazines / Q000494:pharmacology / Q000627:therapeutic use; D006977:Hypertension, Renal / Q000188:drug therapy; D009541:Nictitating Membrane / Q000187:drug effects; D011412:Propanolamines / Q000627:therapeutic use; D011724:Pyridazines / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats
D000959:Antihypertensive Agents; D006834:Hydrazines; D011412:Propanolamines; D011724:Pyridazines